FUFOX regimen

chemotherapy regimen consisting of fluorouracil, folinic acid & oxaliplatin for treatment of metastatic gastric cancer

Networked: 2 relevant articles (1 outcomes, 2 trials/studies)

1.	Bokemeyer, Carsten: 1 article (05/2008)
2.	Hartmann, Jorg Thomas: 1 article (05/2008)
3.	Holtmann, Martin: 1 article (05/2008)
4.	Höhler, Thomas: 1 article (05/2008)
5.	Kröning, Hendrik: 1 article (05/2008)
6.	Pintoffl, Jan Peter: 1 article (05/2008)
7.	Bredenkamp, R: 1 article (07/2005)
8.	Dietzfelbinger, H: 1 article (07/2005)
9.	Duyster, J: 1 article (07/2005)
10.	Hennig, M: 1 article (07/2005)

1.	Stomach Neoplasms (Stomach Cancer) 07/25/2005 - "The weekly FUFOX regimen is well tolerated and shows notable activity as first-line treatment in metastatic gastric cancer." 07/25/2005 - "Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer."
2.	Colorectal Neoplasms (Colorectal Cancer) 05/01/2008 - "The aim of the study was to establish the recommended dose and to evaluate the safety of gefitinib plus FUFOX regimen in irinotecan-refractory colorectal carcinoma (CRC). "